Despite improvement in pathologic complete response with preoperative chemoradiation, the benefit did not extend to overall ...

Third, chemotherapy given as part of concurrent chemoradiation may act systemically and potentially eradicate distant micrometastases.

Positive opinion granted for KEYTRUDA plus chemotherapy for the first-line treatment of adult patients with primary advanced or recurrent endometrial carcinoma who are candidates for systemic therapy, ...

The following is a summary of “Dose-response relationships between radiation exposure, bone marrow function as measured by ...

The published belrestotug/dostarlimab data is still too immature to prove the combination’s capability to disrupt the NSCLC ...

Adding preoperative chemoradiotherapy to perioperative chemotherapy failed to boost survival, versus perioperative ...

1 These data support the conclusion that patients who respond to preoperative chemoradiation therapy, who in this study were represented to a greater degree in the LAR group than in the APR group ...

Research presented at ESMO 2024 could have practice-changing implications for breast, gastrointestinal, genitourinary, and gynecologic cancers.

Janssen-led randomized Phase 2 study evaluating NBTXR3 + chemoradiation followed by anti-PD-L1 for patients with inoperable, stage 3 NSCLC Study may proceed letter received from the Food and Drug ...

Pembrolizumab combined with chemoradiotherapy followed by pembrolizumab monotherapy significantly improved survival compared ...

Radiation and chemo are sometimes used together as chemoradiation. Targeted therapy is another treatment that searches for cancer cells in the body. It is taken by pills and can be taken at home ...

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today reported its consolidated financial ...